Receive The Newest Study Notifications

OnKure, Inc. and the University of Colorado Cancer Center today announced enrollment of the first patient in a first-in-human phase 1 clinical trial testing investigational anti-cancer agent OKI-179, a novel and Class-selective HDAC inhibitor, in patients with...

Takeda has stopped the phase III TOURMALINE-AL1 clinical trial in patients with relapsed or refractory AL amyloidosis because treatment with NINLARO (ixazomib) in combination with dexamethasone did not demonstrate a significant improvement in overall hematologic...

A US-based pharmaceutical company, Aerpio Pharmaceuticals, Inc., recently announced the initiation of Phase 1b clinical trial of AKB-9778 to develop treatment of PAOG (primary open angle glaucoma), report sources. For the record, Aerpio Pharmaceuticals is a...

Parexel, a leader in the development of innovative new therapies to improve the world’s health, today announced a strategic partnership with CLARINESS, a leading global patient recruitment company, to further accelerate clinical trial recruitment and patient...

Rituxan met the primary and secondary endpoints in the Phase III PEMPHIX study Rituxan was the first and only biologic therapy approved by the FDA in June 2018 for the treatment of pemphigus vulgaris based on results from the Ritux 3 clinical trial Results will be...

Intensive urate-lowering strategy may protect against the progression of diabetic kidney disease Madrid, Spain, 13 June 2019: The results of a phase IIa clinical trial presented today at the Annual European Congress of Rheumatology (EULAR 2019) demonstrate a rapid...

Complete radiologic responses linked to T cell activity observed in two of first six evaluable patients IMV to host investor conference call and webcast on June 12, 2019 at 8:00 am ET IMV Inc. (Nasdaq:IMV; TSX:IMV), a clinical stage immuno-oncology corporation, today...

Mechelen, Belgium and Paris, France, 11 JUNE 2019, 07.00 CET - Servier and Galapagos NV(Euronext & NASDAQ: GLPG) completed recruitment for their ROCCELLA Phase 2 trial with GLPG1972/S201086, ahead of schedule. ROCCELLA is a multi-regional, randomized,...

Maximize the amounts ones research site collects with financial audits. Best practices and simple strategies from an industry expert. FALLS CHURCH, Va., June 12, 2019 /PRNewswire-PRWeb/ -- Maximize Your Clinical Trial Fees Put Financial Audits to Work for You **A...

New publication details findings from an industry collaborative workshop on facioscapulohumeral muscular dystrophy LEXINGTON, Mass., June 11, 2019 /PRNewswire-PRWeb/ -- The FSH Society today announced that it has published a report on its recent workshop with...

Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM) today announces that, following receipt of the Dutch investigating centre’s ethics committee approval, it is commencing a clinical study of the effects of its recombinant human C1 esterase...

Novo Nordisk today announced that the PIONEER 6 trial achieved its primary endpoint by demonstrating non-inferiority of major adverse cardiovascular events (MACE) with oral semaglutide compared with placebo, both in addition to standard of care. The primary endpoint...

A new clinical trial investigating the safety and efficacy of Gazyva® (obinutuzumab) for adults with proliferative lupus nephritis (LN) announced encouraging initial results. The study showed that Gazyva, when used in combination with standard LN therapies, helped...

MetVital, Inc., a biopharmaceutical company developing small molecule modulators of glutamate metabolism for the treatment of diseases with significant unmet medical need and commercial potential, today announces that the U.S. Food and Drug Administration (FDA) has...

First-of-its-kind data shows efficacy and safety of a biologic in the management of axial manifestations of psoriatic arthritis (PsA), which affect up to an estimated 35 million people worldwide[1] 66.3% of patients treated with secukinumab 150 mg achieved rapid and...

New study demonstrates synergistic effects of vitamin D and estradiol deficiency on metabolic syndrome Vitamin D and estrogen have already shown well-documented results in improving bone health in women. A new study from China suggests that this same combination could...

While clinical trials tend to focus on helping patients find new ways to conquer their disease and advance scientific understanding, the patient’s experience isn’t always at the center of the conversation. The patient’s safety and well-being are always central, but...

Mechelen, Belgium and Paris, France, 11 JUNE 2019, 07.00 CET - Servier and Galapagos NV (Euronext & NASDAQ:GLPG) completed recruitment for their ROCCELLA Phase 2 trial with GLPG1972/S201086, ahead of schedule. ROCCELLA is a multi-regional, randomized,...

Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM) today announces that, following receipt of the Dutch investigating centre's ethics committee approval, it is commencing a clinical study of the effects of its recombinant human C1 esterase...

The Research Insights added an innovative statistical data of UK Clinical Trial Outsourcing Market. To discover the different aspects of the business, this report uses exploratory techniques, such as primary and secondary research. It provides a valuable source of...